Apraclonidina [Inn-Spanish]
Apraclonidina [Inn-Spanish] Brand names, Apraclonidina [Inn-Spanish] Analogs
Apraclonidina [Inn-Spanish] Brand Names Mixture
- No information avaliable
Apraclonidina [Inn-Spanish] Chemical_Formula
C9H10Cl2N4
Apraclonidina [Inn-Spanish] RX_link
http://www.rxlist.com/cgi/generic2/apraclonidine.htm
Apraclonidina [Inn-Spanish] fda sheet
Apraclonidina [Inn-Spanish] msds (material safety sheet)
Apraclonidina [Inn-Spanish] Synthesis Reference
No information avaliable
Apraclonidina [Inn-Spanish] Molecular Weight
245.108 g/mol
Apraclonidina [Inn-Spanish] Melting Point
No information avaliable
Apraclonidina [Inn-Spanish] H2O Solubility
No information avaliable
Apraclonidina [Inn-Spanish] State
Solid
Apraclonidina [Inn-Spanish] LogP
1.53
Apraclonidina [Inn-Spanish] Dosage Forms
Liquid
Apraclonidina [Inn-Spanish] Indication
For short-term adjunctive therapy in patients on maximally tolerated medical therapy who require additional Intra Ocular Pressure (IOP) reduction.
Apraclonidina [Inn-Spanish] Pharmacology
Apraclonidine significantly lowers intraocular pressure with minimal effects on cardiovascular and pulmonary parameters. It lowers intraocular pressure by reducing aqueous humor production and increasing uveoscleral outflow.
Apraclonidina [Inn-Spanish] Absorption
No information avaliable
Apraclonidina [Inn-Spanish] side effects and Toxicity
No information avaliable
Apraclonidina [Inn-Spanish] Patient Information
No information avaliable
Apraclonidina [Inn-Spanish] Organisms Affected
Humans and other mammals
![Apraclonidina_[Inn-Spanish]](/images/rx/APRD00012.gif)
